शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEKERALA AYURVEDA LTD.· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 21 Oct, 2026 · 13:04 IST

Kerala Ayurveda allots 6,55,000 shares to promoter group at Rs 190.37

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.4%Reaction day
₹144.85
prior close
₹141.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-2.6%+0.2% vs market
Pharmaceuticals peers, median of 172sector-1.7%-0.7% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.9
15m
+0.9
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.4-2.6+0.2-1.7-0.7
Next day
-3.9-3.6-0.3-2.1-1.7
2d
-8.1-5.8-2.3-3.4-4.7
3d
-5.3-5.5+0.2-2.3-2.9
4d
+0.1-3.8+3.9-1.2+1.3
5d
-0.1-3.8+3.7+0.2-0.2
1w
-0.6pendingpending-1.3+0.7
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kerala Ayurveda allotted 6,55,000 equity shares at Rs 190.37 each to Katra Holding Pvt Ltd, a promoter group entity, on a preferential basis. The consideration is by partly adjusting an existing unsecured loan of Rs 12.47 crore. Paid-up capital rose from Rs 12.99 crore to Rs 13.65 crore. Katra Holding stake increases from 4.85 percent to 9.41 percent. Shares will be listed on BSE.

Likely market impact

Promoter group raises stake from 4.85% to 9.41% by converting an unsecured loan into equity. Non-promoter shareholders face slight dilution.